Koers Immunotech Laboratories, Inc. Other OTC
Aandelen
IMMB
US45254F2039
Biotechnologie & Medisch Onderzoek
Omzet * | - | Omzet 1 * | - | Marktkapitalisatie | 57,5K 52,9K |
---|---|---|---|---|---|
Nettowinst (verlies) * | - | Nettowinst (verlies) 1 * | - | EV/omzet * | - |
Nettoliquiditeiten * | - 0 | Nettoliquiditeiten 1 * | - 0 | EV/omzet 1 * | - |
K/w-verhouding * |
-
| K/w-verhouding 1 * |
-
| Werknemers | - |
Dividendrendement * |
-
| Dividendrendement 1 * |
-
| Vrij verhandelbaar | 99,34% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Director/Board Member | 59 | 04-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,77% | 114 mld. | |
+11,18% | 104 mld. | |
-12,83% | 22,41 mld. | |
-1,08% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,50% | 17,89 mld. | |
+7,81% | 14,28 mld. | |
+36,05% | 12,55 mld. |